Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryo Morita

Showing results (71-80 of 98) with videos related to

Pageof 10
Sort By:
The British Journal of Radiology|January 12, 2023
Study of hepatic toxicity in small liver tumors after photon or proton therapy based on factors predicting the benefits of protonYusuke Uchinami, Norio Katoh, Daisuke Abo, et al.
The Lancet. Respiratory Medicine|October 1, 2025
Durvalumab, carboplatin, and etoposide in patients who are treatment-naive with extensive-stage small-cell lung cancer and poor performance status (NEJ045A): a single-arm phase 2 trialTetsuhiko Asao, Yu Saida, Satoshi Watanabe, et al.
World Journal of Gastroenterology|April 19, 2014
An updated review of gastric cancer in the next-generation sequencing era: insights from bench to bedside and vice versaHiroyuki Yamamoto, Yoshiyuki Watanabe, Tadateru Maehata, et al.
Digestion|November 8, 2011
Gastric wash-based molecular testing for antibiotic resistance in Helicobacter pyloriSatoshi Baba, Yoshichika Oishi, Yoshiyuki Watanabe, et al.
European Journal of Cancer (Oxford, England : 1990)|March 26, 2023
Phase 2 study of osimertinib in combination with platinum and pemetrexed in patients with previously untreated EGFR-mutated advanced non-squamous non-small cell lung cancer: The OPAL StudyRyota Saito, Shunichi Sugawara, Ryo Ko, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 24, 2021
Treatment outcomes of stereotactic body radiation therapy using a real-time tumor-tracking radiotherapy system for hepatocellular carcinomasYusuke Uchinami, Norio Katoh, Daisuke Abo, et al.
Lung Cancer (Amsterdam, Netherlands)|May 23, 2025
A treatment-related death predictive score for treatment-naïve advanced non-small cell lung cancerShogo Nomura, Yuta Sekino, Yoshimasa Shiraishi, et al.
Iscience|May 1, 2023
COVID-19 relapse associated with SARS-CoV-2 evasion from CD4<sup>+</sup> T-cell recognition in an agammaglobulinemia patientRyo Morita, Ritsuko Kubota-Koketsu, Xiuyuan Lu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 9, 2025
Gut Microbiota in Advanced NSCLC Receiving Chemoimmunotherapy: An Ancillary Biomarker Study From the Phase III Trial JCOG2007 (NIPPON)Taiki Hakozaki, Kentaro Tanaka, Yoshimasa Shiraishi, et al.
Lung Cancer (Amsterdam, Netherlands)|April 19, 2021
Prognostic factors in patients with advanced non-small cell lung cancer after long-term Anti-PD-1 therapy (HOT1902)Shotaro Ito, Hajime Asahina, Osamu Honjo, et al.
Pageof 10

Showing results (71-80 of 98) with videos related to

Sort By:
Pageof 10
The British Journal of Radiology|January 12, 2023
Study of hepatic toxicity in small liver tumors after photon or proton therapy based on factors predicting the benefits of protonYusuke Uchinami, Norio Katoh, Daisuke Abo, et al.
The Lancet. Respiratory Medicine|October 1, 2025
Durvalumab, carboplatin, and etoposide in patients who are treatment-naive with extensive-stage small-cell lung cancer and poor performance status (NEJ045A): a single-arm phase 2 trialTetsuhiko Asao, Yu Saida, Satoshi Watanabe, et al.
World Journal of Gastroenterology|April 19, 2014
An updated review of gastric cancer in the next-generation sequencing era: insights from bench to bedside and vice versaHiroyuki Yamamoto, Yoshiyuki Watanabe, Tadateru Maehata, et al.
Digestion|November 8, 2011
Gastric wash-based molecular testing for antibiotic resistance in Helicobacter pyloriSatoshi Baba, Yoshichika Oishi, Yoshiyuki Watanabe, et al.
European Journal of Cancer (Oxford, England : 1990)|March 26, 2023
Phase 2 study of osimertinib in combination with platinum and pemetrexed in patients with previously untreated EGFR-mutated advanced non-squamous non-small cell lung cancer: The OPAL StudyRyota Saito, Shunichi Sugawara, Ryo Ko, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 24, 2021
Treatment outcomes of stereotactic body radiation therapy using a real-time tumor-tracking radiotherapy system for hepatocellular carcinomasYusuke Uchinami, Norio Katoh, Daisuke Abo, et al.
Lung Cancer (Amsterdam, Netherlands)|May 23, 2025
A treatment-related death predictive score for treatment-naïve advanced non-small cell lung cancerShogo Nomura, Yuta Sekino, Yoshimasa Shiraishi, et al.
Iscience|May 1, 2023
COVID-19 relapse associated with SARS-CoV-2 evasion from CD4<sup>+</sup> T-cell recognition in an agammaglobulinemia patientRyo Morita, Ritsuko Kubota-Koketsu, Xiuyuan Lu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 9, 2025
Gut Microbiota in Advanced NSCLC Receiving Chemoimmunotherapy: An Ancillary Biomarker Study From the Phase III Trial JCOG2007 (NIPPON)Taiki Hakozaki, Kentaro Tanaka, Yoshimasa Shiraishi, et al.
Lung Cancer (Amsterdam, Netherlands)|April 19, 2021
Prognostic factors in patients with advanced non-small cell lung cancer after long-term Anti-PD-1 therapy (HOT1902)Shotaro Ito, Hajime Asahina, Osamu Honjo, et al.
Pageof 10